Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 0 | 0 | 80,000 | 0 | 871 |
| Gross Profit | N/A | N/A | 80,000 | N/A | 871 |
| Operating Expenses | 19,429 | 25,126 | 27,508 | 29,834 | 28,863 |
| Operating Income | -19,429 | -25,126 | 52,492 | -29,834 | -27,992 |
| Other Income | 2,861 | 3,430 | 2,917 | 2,964 | 3,236 |
| Pre-tax Income | -16,568 | -21,696 | 55,409 | -26,870 | -24,756 |
| Net Income Continuous | -16,568 | -21,696 | 55,409 | -26,870 | -24,756 |
| Net Income | $-16,568 | $-21,696 | $55,409 | $-26,870 | $-24,756 |
| EPS Basic Total Ops | -0.27 | -0.35 | 0.89 | -0.43 | -0.41 |
| EPS Basic Continuous Ops | -0.27 | -0.35 | 0.89 | -0.43 | -0.40 |
| EPS Diluted Total Ops | -0.25 | -0.35 | 0.87 | -0.43 | -0.41 |
| EPS Diluted Continuous Ops | -0.25 | -0.35 | 0.87 | -0.43 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -0.31 | -0.35 | 0.87 | -0.43 | N/A |
| EBITDA(a) | $-19,060 | $-24,757 | $52,868 | $-29,355 | $-27,484 |